PreveCeutical Medical Inc. (CSE:PREV)

Canada flag Canada · Delayed Price · Currency is CAD
0.0500
-0.0050 (-9.09%)
Oct 30, 2025, 3:57 PM EDT
-9.09%
Market Cap29.34M
Revenue (ttm)n/a
Net Income (ttm)-2.60M
Shares Out586.81M
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,607,553
Average Volume632,999
Open0.0600
Previous Close0.0550
Day's Range0.0500 - 0.0600
52-Week Range0.0150 - 0.0550
Beta0.05
RSI64.68
Earnings DateNov 28, 2025

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; and BSV Peptide Program that targets cancer progression. The company is headquartered in West Vancou... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Stephen Van Deventer
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PREV
Full Company Profile

Financial Performance

Financial Statements

News

PreveCeutical Medical (PRVCF) Expands Private Placement to $1.2M

PreveCeutical Medical (PRVCF) Expands Private Placement to $1.2M

18 days ago - GuruFocus

PreveCeutical Medical boosts private placement to $1.2M, following shareholder meeting approvals

PreveCeutical Medical (PRVCF) announced that shareholders approved all resolutions presented at the Annual General and Special Meeting and upsized its previously announced private placement financing ...

18 days ago - Seeking Alpha